Transdermal penetrant formulations containing cannabidiol

A method of treating a patient with an ailment by applying a transdermal formulation to the skin of the patient, the transdermal formulation comprising the following components:

• a. Cannabidiol at a concentration from 1% to 7%;
• b. a phosphatidylcholine at a concentration from 4% to 15%;
• c. glucose at a concentration from 0% to 3%;
• d. benzyl alcohol at a concentration from 0.25% to 5%;
• e. deionized water at a concentration from 10% to 75%;
• f. safflower oil at a concentration from 1% to 20%;
• g. oleic acid at a concentration from 0.2% to 7.5%;
• h. stearic acid at a concentration from 0.1% to 7%;
• and
• i. isopropyl palmitate at a concentration from 5% to 30%,
• wherein the ailment is pain, seizures or Parkinson's disease and wherein all amounts are percent by weight relative to the total weight of said transdermal formulation (w/w).